Clinical trial
Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
NCT00242190 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- February 28, 2010
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.